Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA-LNP vaccination-based immunotherapy augments CD8+ T cell responses against HPV-positive oropharyngeal cancer
Ke Qiu, Xing Duan, Minzi Mao, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

The 60-year evolution of lipid nanoparticles for nucleic acid delivery
Pieter R. Cullis, Philip L. Felgner
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 709-722
Closed Access | Times Cited: 45
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use
Yu Zhang, Ke Qiu, Jianjun Ren, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
Fatemeh Movahed, Satinik Darzi, Parya Mahdavi, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Biodistribution of RNA Vaccines and of Their Products: Evidence from Human and Animal Studies
Ildus Pateev, Kristina Seregina, Roman Ivanov, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 59-59
Open Access | Times Cited: 19
Emerging advances in delivery systems for mRNA cancer vaccines
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
pH‐Responsive β‐Glucans‐Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer Immunotherapy
Po‐Kai Luo, Hui‐Min Ho, Min‐Chun Chiang, et al.
Advanced Materials (2024) Vol. 36, Iss. 33
Closed Access | Times Cited: 5
Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
D. N. Kisakov, Л. И. Карпенко, L. A. Kisakova, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 65-65
Open Access
Neoantigen mRNA vaccines and A 2 A receptor antagonism: A strategy to enhance T cell immunity
Saber Imani, Parham Jabbarzadeh Kaboli, Ali Babaeizad, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer
Rama Rao Malla, Mundla Srilatha, Batoul Farran, et al.
Molecular Therapy (2023) Vol. 32, Iss. 1, pp. 13-31
Open Access | Times Cited: 12
Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies
Jing Wang, Ling Ma, Yunfeng Chen, et al.
Life Science Alliance (2024) Vol. 7, Iss. 6, pp. e202302448-e202302448
Open Access | Times Cited: 4
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends
Yu Gao, Liang Yang, Zhenning Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Biodistribution of lipid nanoparticle, eGFP mRNA and translated protein following subcutaneous administration in mouse
Åsa Sandelius, Humaira Naseer, Johnny Lindqvist, et al.
Bioanalysis (2024) Vol. 16, Iss. 14, pp. 721-733
Closed Access | Times Cited: 2
Potential Therapeutic Targets for the Treatment of HPV-Associated Malignancies
Ziyao Lu, Shahab Haghollahi, Muhammad Zubair Afzal
Cancers (2024) Vol. 16, Iss. 20, pp. 3474-3474
Open Access | Times Cited: 2
Targeting the oral tumor microenvironment by nanoparticles: A review of progresses
Haosheng Zhang, Fangzheng Zhou, Qiuyu Yang, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105248-105248
Closed Access | Times Cited: 7
Nucleic acid‐based vaccine for ovarian cancer cells; bench to bedside
Sulieman Ibraheem Shelash Al‐Hawary, Saade Abdalkareem Jasim, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 1
The future of genetic medicines delivered via targeted lipid nanoparticles to leukocytes
Dana Tarab‐Ravski, Lior Stotsky‐Oterin, Aviad Elisha, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 286-302
Closed Access | Times Cited: 1
Molecular and transcriptional basis of bidirectional CD4+ T cell exhaustion in oropharyngeal squamous cell carcinoma
Danni Cheng, Ke Qiu, Daibo Li, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 1
A Self-Amplifying Human Papillomavirus 16 Vaccine Candidate Delivered by Tobacco Mosaic Virus-Like Particles
Sweta Karan, Jessica Fernanda Affonso de Oliveira, Miguel A. Moreno‐Gonzalez, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 11, pp. 7675-7683
Closed Access
Personalized Membrane Protein Vaccine Based on a Lipid Nanoparticle Delivery System Prevents Postoperative Recurrence in Colorectal Cancer Models
Guoliang Shi, Yuandong Xu, Hengwei Qiu, et al.
Acta Biomaterialia (2024) Vol. 192, pp. 315-327
Closed Access
Lipid Nanoparticle (LNP) Delivery Vector-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top